These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 4039669

  • 1. Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy.
    Robertson A, MacDonald C.
    Eur J Pharmacol; 1985 Feb 12; 109(1):81-9. PubMed ID: 4039669
    [Abstract] [Full Text] [Related]

  • 2. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A, MacDonald C.
    Pharmacol Biochem Behav; 1986 Jun 12; 24(6):1639-43. PubMed ID: 2874567
    [Abstract] [Full Text] [Related]

  • 3. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A, MacDonald C.
    Pharmacol Biochem Behav; 1984 Jul 12; 21(1):97-101. PubMed ID: 6540455
    [Abstract] [Full Text] [Related]

  • 4. The effects of metoclopramide, sulpiride, and the stereoisomers of baclofen on amphetamine-induced behavior in the marmoset.
    Ridley RM, Scraggs PR, Baker HF.
    Biol Psychiatry; 1980 Apr 12; 15(2):265-74. PubMed ID: 7191332
    [Abstract] [Full Text] [Related]

  • 5. Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion.
    Moore S, Kenyon P.
    Psychopharmacology (Berl); 1994 Feb 12; 114(1):123-30. PubMed ID: 7846194
    [Abstract] [Full Text] [Related]

  • 6. Metoclopramide potentiates d-amphetamine-induced hypermotility and stereotypy in rat.
    Howard JL, Pollard GT, Craft RM, Rohrbach KW.
    Pharmacol Biochem Behav; 1987 May 12; 27(1):165-9. PubMed ID: 3615538
    [Abstract] [Full Text] [Related]

  • 7. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R, Guerin JJ, Davis KL.
    Psychopharmacology (Berl); 1989 May 12; 98(3):386-91. PubMed ID: 2568659
    [Abstract] [Full Text] [Related]

  • 8. Differential behavioural interactions between the dopamine D-1 antagonist SCH 23390 and the dopamine D-2 antagonists metoclopramide and sulpiride in nonhabituated mice.
    Chandler CJ, Starr BS, Starr MS.
    Pharmacol Biochem Behav; 1990 Feb 12; 35(2):285-9. PubMed ID: 2181484
    [Abstract] [Full Text] [Related]

  • 9. [Possible discrepancy between behavioral adequacy and motor automatisms in cats with phenamine-induced stereotypy].
    Tolpyshev BA, Smirnova LE, Arushanian EB.
    Biull Eksp Biol Med; 1981 Aug 12; 92(8):46-8. PubMed ID: 7197561
    [Abstract] [Full Text] [Related]

  • 10. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT, Rebec GV.
    Pharmacol Biochem Behav; 1988 Nov 12; 31(3):519-22. PubMed ID: 3251235
    [Abstract] [Full Text] [Related]

  • 11. Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic, thioridazine.
    Bentall AC, Herberg LJ.
    Neuropharmacology; 1980 Aug 12; 19(8):699-703. PubMed ID: 7191488
    [No Abstract] [Full Text] [Related]

  • 12. Amphetamine-induced locomotor stereotypy in rats is reduced by a D1 but not a D2 antagonist.
    Fritts ME, Mueller K, Morris L.
    Pharmacol Biochem Behav; 1997 Dec 12; 58(4):1015-9. PubMed ID: 9408208
    [Abstract] [Full Text] [Related]

  • 13. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K.
    Pharmacol Biochem Behav; 1993 May 12; 45(1):71-6. PubMed ID: 8100075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Nov 12; 40(1):9-19. PubMed ID: 791660
    [Abstract] [Full Text] [Related]

  • 16. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J.
    Eur J Pharmacol; 1983 May 20; 90(1):47-55. PubMed ID: 6135618
    [Abstract] [Full Text] [Related]

  • 17. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
    Gordon JH, Clopton JK, Curtin JC, Koller WC.
    Pharmacol Biochem Behav; 1987 Feb 20; 26(2):223-8. PubMed ID: 3575347
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Time course of amphetamine-induced locomotor stereotypy in an open field.
    Mueller K, Kunko PM, Whiteside D, Haskett C.
    Psychopharmacology (Berl); 1989 Feb 20; 99(4):501-7. PubMed ID: 2594917
    [Abstract] [Full Text] [Related]

  • 20. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 20; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.